A clinical study by using loha amrutama with navayasa churna in iron deficiency anaemia.

Phase 4

Not yet recruiting

• Conditions: Iron deficiency. Ayurveda Condition: PANDUROGAH,

• Registration Number: CTRI/2023/04/051705
• Lead Sponsor: DrNikita Sunil Singh

Brief Summary

Iron deficiency anaemia is most common nutrition deficiency disorder worldwide. According to National family health survey data the incidence of anaemia is 79 % the national family health survey data suggests that the prevalence of anaemia in adolscent is 56%. In Ayurveda iron deficiency anaemia can correlate with Pandu roga. Ayurveda combinations indicated for Pandu comprise of other Drugs along with Loha/ Mandur bhasma.

So, beauty of Ayurveda preparation lies in assuring digestion, metabolism and excretion (after complete utilisation) of the doing without any untoward reactions and side effects.

In this trial, I have selected two drugs for my clinical trial with almost equal quantity of Loha bhasma(to avoid bias) .In due course of trial, I shall study mode of action, indication of the drug and efficacy as well.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2023-04-13
• Study Start: 2023-04-23

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patient having Prayatma lakshanas of pandu roga Pandutha Arohan Ayasa Pindikodweshtana Klama Hb Percentage between 7-12g% male & 7-10g% in females.

Exclusion Criteria

• Pregnant women & lactating mothers.
• Patients suffering from infectious diseases.
• Patients who has acute or chronic blood loss.
• Patients with systemic disorders that would interfere with course of the study.
• All types of secondary, congenital and hereditary anaemia.
• Patients who do not give consent for treatment.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To check the improvement in the symptoms mentioned in the subjective and objective criteria on respective follow ups.	10th day,20th day,30th day

Secondary Outcome Measures

Name	Time	Method
To find out the adverse effect of Loha amrutama on respective follow ups.	1Oth day,20th day,30th day

Trial Locations

Locations (1)

Sheth R.V. ayurvedic hospital and Sheth V.M.charitable dispensary; 🇮🇳 Mumbai, MAHARASHTRA, India

Sheth R.V. ayurvedic hospital and Sheth V.M.charitable dispensary

🇮🇳Mumbai, MAHARASHTRA, India

DrNikita Sunil Singh

Principal investigator

8879324863

nikitasingh4863@gmail.com